#Healthcare

Real-World Data Solutions

Vendors are exploring ways to consolidate traditionally fragmented real-world data (RWD) sources and turn them into real-world evidence (RWE) capable of generating meaningful insights for pharma, patients and payors. The next few years could prove transformative for investors, vendors, patients and the healthcare system as a whole.

As active investors in the life sciences and tech services, LLR is watching the space closely. Intermediaries working with firms in the real-world data solutions space should contact Will Sadock to discuss relevant opportunities to invest in and support their growth.

Rapid advances in technology have the potential to shine a powerful floodlight on this mass of valuable, non-clinical trial sourced data, a development that is already starting to ease persistent bottlenecks, to identify more off-label uses for therapies and to help create a more accessible and effective healthcare system.

Will Sadock, Vice President, LLR Partners

Tailwinds that Further Accelerate Demand for RWD and RWE

Use of RWE during the pandemic: This proved to be an effective way to accelerate vaccine testing by tracking real-world patient outcomes and measuring the efficacy of interventions.

Regulatory acceptance: The FDA established an RWE framework, grants to encourage the use of RWE in clinical trials, and a formal program to improve the quality of RWE-based approaches.

 

Technological advances: Over the past two decades, technological advances have brought far more powerful computational capacity within reach, contributing to the robust growth of advanced analytics across the data solutions market for life sciences.

 

The value proposition for real-world data solutions

30%
1
of the global datasphere is healthcare data
120%
2
increase in the use of RWE in regulatory submissions
90%
3
of pharmaceutical companies now have RWD/E teams

Key Focus Areas for LLR Investment

Our areas of focus for investment span data solutions that support drug discovery, clinical trial optimization, market access and intelligence, HCP targeting, post-launch surveillance and beyond:

Data acquisition solutions, including vendors capable of aggregating or linking disparate datasets or who own or have access to datasets such as claims, registries and medical records, genomics, patient-generated, medical device or clinical software.

Data management solutions, including vendors offering pharma-specific platforms or environments to collect, store, process and visualize diverse data.

Data analytics solutions, including vendors offering purpose-built platforms that transform RWD into RWE and mine client data for insights across clinical and commercial use-cases and consultancies offering tech-enabled offerings around life science data and analytics.

Our Strategic Network

Portfolio companies gain access to LLR’s in-house Value Creation and Market Development teams, along with our extensive network of industry relationships, built over 25 years of investing in healthcare businesses.

Select Investment Experience

LLR invests in the sectors where our investment experience indicates there are attractive business models and market trends supporting strong growth potential. Here are some of our related investments.

See You There?

October 20, 2024
HLTH
Learn More
October 24, 2024
DIA Real World Evidence Conference
Learn More
October 29, 2024
IMPACCT Real World Evidence Summit
Learn More
February 3, 2025
SCOPE Real World Evidence Summit
Learn More

Latest GrowthBits

View All
#Healthcare
Clinical Trials Offer Rays of Healthcare Insight. Real-World Data Promises a Floodlight
William Sadock & Matt McKinley

Meet the LLR Team

Zack Sigal

Zack Sigal
William Sadock

William Sadock
Tyler Wincig

Tyler Wincig
Parker Heisey

Parker Heisey

Related News

News

September 8, 2022

LLR Partners Announces Significant Growth Investment in VPL

LLR Partners today announced a significant growth investment in Vantage Point Logistics (“VPL”), a supply chain management software provider that helps...

News

July 1, 2015

Health Information Companies HealthPort and IOD Merge

Merger to create nation’s leading platform for secure clinical data solutions; positions company for continued innovation and growth. In May...

References

  1. “The Healthcare Data Explosion, Episode 1,” RBC Capital Markets: Navigating the Changing Face of Healthcare, 2024, https://www.rbccm.com/en/gib/healthcare/episode/the_healthcare_data_explosion
  2. Shelley, Suzanne. “Pharma’s Business Case for RWE: Tapping the Full Value From These Insights,” PharmaExec.com, 2023, https://www.pharmexec.com/view/pharma-business-case-rwe-tapping-full-value-from-these-insights
  3. Morgan, et. all, “Real-world evidence’s evolution into a true end-to-end capability,” Deloitte Insights, Deloitte, 2023, https://www2.deloitte.com/us/en/insights/industry/health-care/real-world-evidence-study.html
Disclaimer:

The information presented herein is intended for an audience of potential LLR portfolio companies and the intermediaries supporting their capital raise processes. Named LLR investments presented herein do not reflect a complete list of LLR investments and are provided for informational purposes only. Certain statements about LLR made by portfolio company executives and other quoted parties herein are intended to illustrate the work of LLR’s Value Creation Team with such portfolio companies or reflect the individual’s perspective on the featured industry sector. Such portfolio companies are controlled by investment vehicles managed by LLR. Quoted parties were not compensated in connection with their participation, although they generally receive compensation and investment opportunities in connection with their portfolio company or Senior Operating Advisor roles, and in certain cases are also owners of portfolio company securities and/or investors in LLR-sponsored vehicles. Such compensation and investments subject participants to potential conflicts of interest in making the statements herein.